Skip to main content
Signal8

Agarwal Arjun

SEC insider (Form 3/4/5 filer). CIK 0002033974. Senior Vice President, Finance at Oruka Therapeutics, Inc. (ORKA). 44 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in MENLO PARK, CA.

Companies Agarwal Arjun has filed insider reports for

  • Oruka Therapeutics, Inc. (ORKA): Officer, Senior Vice President, Finance
Agarwal Arjun profile photo

Agarwal Arjun

CIK: 0002033974

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)30 (68.2%)

Position reduction

Option Exercises (M)12 (27.3%)

Derivative conversions

Awards (A)2 (4.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Oruka Therapeutics, Inc. logo
ORKA

Oruka Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (44 total)

  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Oct 12, 2026
    Sale
    Direct
    2.1K shares at avg. $80.76$170K
  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Oct 12, 2026
    Exercise
    Direct
    8.5K shares at avg. $12.50$107K
  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Oct 12, 2026
    Exercise
    Direct
    1.5K shares at avg. $34.39$50K
  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Oct 12, 2026
    Sale
    Direct
    2K shares at avg. $81.86$160K
  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Oct 12, 2026
    Sale
    Direct
    200 shares at avg. $82.83$17K
  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Oct 12, 2026
    Sale
    Direct
    5.7K shares at avg. $80.03$459K
  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Sep 21, 2026
    Sale
    Direct
    533 shares at avg. $95.75$51K
  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Sep 15, 2026
    Sale
    Direct
    560 shares at avg. $95.71$54K
  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Sep 11, 2026
    Exercise
    Direct
    8K shares at avg. $12.50$100K
  • Oruka Therapeutics, Inc. logo
    ORKA

    Oruka Therapeutics, Inc.

    Sep 11, 2026
    Exercise
    Direct
    1.5K shares at avg. $34.39$50K

1-10 of 44